期刊文献+

成人朗格汉斯细胞组织细胞增生症1例并文献复习 被引量:1

Adult Langerhans Cell Histiocytosis A Case Report and Literature Review
下载PDF
导出
摘要 目的探讨成人朗格汉斯细胞组织细胞增生症(LCH)的临床、组织病理学、免疫表型。方法报告1例罕见的皮损类似播散性黄瘤的成人朗格汉斯细胞组织细胞增生症,并结合文献分析其临床及病理特征。结果该病例表现有皮肤、骨骼、垂体三系统损害。先后经过2次皮损活检及1次骨骼活检,皮损组织学特点为真皮全层弥漫分布的组织细胞,其CD1a表达阴性而S-100表达阳性,受损骨骼组织学显示典型嗜酸性肉芽肿表现,CD1a,S-100均表达阳性。结论成人朗汉斯细胞组织细胞增生症罕见,误诊率高。应结合多系统临床表现及组织学特征、免疫表型综合分析。 Objective To investigate the clinical and pathological,immunophenotypical microscopical features of lange- rhans cell histiocytosis (LCH). Methods An adult LCH was reported, accompanied by accompanied by lesions similar to xanthoma and osteolysis. The clinicopathological features were summarized by literature review. Results The case showed three system damages of skin, bones, and pituitary. Pathological exa mina- tion of skin lesion showed diffuse histocyte infiltration, with positive S-100 and negative CD10a. Pathological examination of femur showed typical eosinophilic granuloma, with positive S-100 and positive CDIOa. The lesion removed from femur was positive for S-100 and CDla. Conclusion Adult langerhans cell histiocytosis is extremely rare. The clinical presentation of LCH is highly variable.
作者 孙婷 晏洪波
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2015年第7期715-717,共3页 The Chinese Journal of Dermatovenereology
关键词 组织细胞增生症 朗格汉斯细胞 成人 Langerhans cell histiocytosis Langerhans cell Adult
  • 相关文献

参考文献7

  • 1Haroche J, Charlotte F, Amaud L, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non- Langerhans cell histiocytoses [J]. Blood, 2012, 120 ( 13 ) : 2700 - 2703.
  • 2Tsuji Y, Kanegane H, Fujimoto J, et al. Evans syndrome in a patient with Langethans cell histioeylosis: possible pathogenesis of autoimmunity in LCH [J]. lnt J Hematol,2008,8( 1 ) :75 -77.
  • 3Girschikofsky M, Arico M, Castillo D, et al. Management of adult patients with Langerhans cell histioeytosis: recommendations from an expert panel on behalf of Euro-Histio-Net [J]. Orphanet J Rare Dis, 2013,8:72.
  • 4Me Dermott R,Ziylan U, Spehner D, et al. Birbeek grmmles are subdo- mains of endosomal recycling compartment in human epidermal Langer- hans cells,which form where Langerin accumulates [ J]. Mol Biol Cell, 2002,13( 1 ) :317 -335.
  • 5吴升华.郎格罕细胞组织细胞增生症评估与治疗指南介绍[J].中华儿科杂志,2012,50(2):155-158. 被引量:68
  • 6Donadieu J, Chalard F, Jeziorski E. Medical management of langerhans cell histiocytosis from diagnosis to treatment [ J ]. Expert Opinion on Pharmacotherapy ,2012,13 (9) : 1309 - 1322.
  • 7Furodate S, Fujimura T, Kambayashi Y, et al. Successful treatment of adult onset Langerhans cell histiocytosis with bi-weekly ad ministration of pegylated interferon-et [ J ]. Acta Derm Venereol, 2014,94 ( 5 ) : 611 -612.

二级参考文献13

  • 1王宏胜,李军,马伴吟,高怡瑾,陆凤娟,钱晓文.改良DAL-HX83/90方案治疗儿童郎格罕细胞组织细胞增生症24例疗效观察[J].中国小儿血液与肿瘤杂志,2007,12(2):60-63. 被引量:12
  • 2Histiocyte Society. Langerhans cell histiocytosis evaluation and treatment guideline. April,2009. Availabele from : http ://www. heamatologie-amc, nl/odijk/bijlagen.
  • 3Minkov M. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Paediatr Drugs, 2011,13 : 75 -86.
  • 4Gadner I-I, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histioeytosis. J Pediatr, 2001, 138:728-734.
  • 5treatment ot multisystem Langerhans cell histiocytosis : important prognostic indicator. Med Pediatr Oncol, 2002,39:581- 585.
  • 6Bernard F, Thomas C, Bertrand Y,et al. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside corobined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. Eur J Cancer, 2005,41:2682-2689.
  • 7Steiner M, Matthes-Martin S, Attarbaschi A, et al. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced- intensity conditioning. Bone Marrow Transplant, 2005,36: 215- 225.
  • 8Egeler RM, de Kraker J, Vo6te PA. Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Med Pediatr Oncol, 1993,21: 265-270.
  • 9Stine KC, Saylors RL, Williams LL, et al. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol, 1997,29: 288-292.
  • 10Stine KC, Saylors RL, Saccente S, et al. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis. Pediatr Blood Cancer, 2004,43:81-84.

共引文献67

同被引文献30

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部